Syndax Pharmaceuticals (SNDX) Shares Outstanding (Weighted Average): 2015-2024
Historic Shares Outstanding (Weighted Average) for Syndax Pharmaceuticals (SNDX) over the last 10 years, with Dec 2024 value amounting to $85.4 million.
- Syndax Pharmaceuticals' Shares Outstanding (Weighted Average) rose 1.23% to $86.1 million in Q3 2025 from the same period last year, while for Dec 2020 it was $40.9 million, marking a year-over-year increase of 50.58%. This contributed to the annual value of $85.4 million for FY2024, which is 22.57% up from last year.
- According to the latest figures from FY2024, Syndax Pharmaceuticals' Shares Outstanding (Weighted Average) is $85.4 million, which was up 22.57% from $69.6 million recorded in FY2023.
- Syndax Pharmaceuticals' Shares Outstanding (Weighted Average)'s 5-year high stood at $85.4 million during FY2024, with a 5-year trough of $40.9 million in FY2020.
- For the 3-year period, Syndax Pharmaceuticals' Shares Outstanding (Weighted Average) averaged around $74.5 million, with its median value being $69.6 million (2023).
- Data for Syndax Pharmaceuticals' Shares Outstanding (Weighted Average) shows a peak YoY soared of 50.58% (in 2020) over the last 5 years.
- Over the past 5 years, Syndax Pharmaceuticals' Shares Outstanding (Weighted Average) (Yearly) stood at $40.9 million in 2020, then climbed by 20.85% to $49.4 million in 2021, then skyrocketed by 38.57% to $68.4 million in 2022, then rose by 1.75% to $69.6 million in 2023, then rose by 22.57% to $85.4 million in 2024.